Oracle Is Growing 30% and Selling at Half Its Peak. The Cash Flow Tells You Why

Oracle just handed investors exactly what they have been asking for, and the stock once again handed it back. On September 10 it reported fiscal first-quarter results that beat on both lines—adjusted earnings of $1.92 a share against the $1.74 consensus and revenue up roughly 30%, and shares jumped about 7% in extended trading. By the next session the gain was gone, and the stock was trading back below where it closed before the report. It sits near $153, about half what it fetched at its September 2025 high and at a double-digit loss for the year.

That pattern is the whole story in miniature. Oracle's growth is not in dispute. What the market keeps refusing to pay for is the cost of getting it.

The backlog analysts are pointing at

The bull case is laid out in a handful of numbers. Cloud infrastructure revenue more than doubled to $7.4 billion, up 121% from a year earlier. Total revenue hit $19.35 billion, and management raised full-year guidance to at least $90 billion in revenue and $8.10 in adjusted earnings—both above what Wall Street had modeled going in.

The number that really drives the optimists is the backlog. Remaining performance obligations, the value of contracts signed but not yet delivered, reached $664 billion, ahead of the roughly $630 billion consensus. Backlog is why the analysts keep raising targets while the stock falls. Barclays lifted its price target to $250 from $240 in June and kept its Overweight rating; the sell-side average sits near $242, and Guggenheim's firm-wide high is $400. AInvest's aggregate signal labels the stock a Buy, and the Street overall runs about thirty buys against one sell.

Under almost any growth lens, Oracle looks like the mispriced thing. On the trailing numbers it trades near 24 times earnings—not dramatically richer than IBM at about 21 or Salesforce near 21—and against roughly 30% revenue growth that works out to a price-to-growth ratio around 0.5, the kind of figure value screens light up for. If growth alone priced the stock, the analysts would be right and the stock would be a bargain at half its peak.

The cash the market is demanding

Here is where the growth lens and the cash lens stop matching. Oracle spent $28.5 billion on capital expenditures in a single quarter and generated $23.1 billion of operating cash flow, leaving negative free cash flow of about $5 billion. A year earlier that deficit was only about $362 million. The burn is accelerating, not leveling.

Management guided full-year capital spending to a record $90 billion to $95 billion. The company finished the quarter having raised another $20 billion through an at-the-market equity issuance, and it carries on the order of $125 billion of long-term debt. In other words, the buildout is being funded with borrowed money and newly issued shares, and until those data centers turn profitable, the earnings the analysts model are being underwritten by capital rather than produced as cash.

Two more facts make the safety problem structural rather than temporary. First, roughly half of that backlog traces to OpenAI, a single customer. A backlog is contracted, not free; if the biggest name in it stumbles, the conversion to cash slows with it. Second, the thing that usually makes a 30%-grower cheap—a forward multiple lower than its trailing one, as growth compounds—is not showing up here, because so much of the "growth" is a bill being paid with debt and dilution rather than profit that lands in free cash flow.

What a factor reader does with it

Ranked against its software peers, Oracle is the one company in the group running this capital-intensity trade. IBM and Salesforce grow slower but generate cash; Oracle grows faster and burns it. That is the whole sector-relative distinction. On valuation Oracle is not obviously dear, and it is not obviously cheap either—it carries a higher price-to-sales multiple than IBM or Salesforce, and on any forward basis the discount its growth would normally earn is spent on financing.

Put the grades together and Oracle is a growth story with a deteriorating safety grade, and the market has noticed: the stock has traded below its 200-day average for months, and its triple-digit volatility means every report is a coin flip for the shares regardless of the numbers.

That makes its portfolio role specific rather than a generic "buy the dip." This is a payoff trade, not a value trade and not a momentum trade. The reward is real—if the backlog converts and free cash flow turns positive while this customer-concentrated book holds up, the analyst targets stop looking absurd, and today's price is the discounted version of that ending. The risk is that the conversion never arrives and the financing keeps compounding before revenue does.

The single variable that turns the whole debate is free cash flow. Watch whether the deficit narrows as the new data centers come online and switch their contracts from capital-hungry to self-funding—and whether the OpenAI concentration starts to fray. Until that trend flips, every well-reasoned price-target increase is being priced against a balance sheet that has not yet caught up with its own ambition.